Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Ancora Indonesia Resources Tbk. (OKAS) Price & Performance

UBC Medical Indonesia Tbk.Trade
Ancora Indonesia Resources Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Ancora Indonesia Resources Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Ancora Indonesia Resources Tbk. trades at Rp100 (market cap 237.34B, 493.1K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.4× Ancora Indonesia Resources Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 493.1K). Which is the better fit depends on your goals.

LABSOKAS
Market Cap
576.7B237.34B
Volume
3.48M493.1K
Lot
34.82K4.93K
Turnover
522.79M49.55M
Average Price
150.13100.49
Value
522.79M49.55M
Indicative Equilibrium Price
148101
Indicative Equilibrium Volume
3502

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
OKAS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Ancora Indonesia Resources Tbk.

PT Ancora Indonesia Resources Tbk (the Company) was establised on September 15, 2003. Based to the Extraordinary General Meeting of Shareholders,all shareholders approved the change of the Company's name from PT TD Resources Tbk to PT Ancora Indonesia Resources Tbk. This change of the Company's name was effective on December 3, 2008.

Read more on OKAS